METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PATIENTS SUFFERING FROM MYELOPROLIFERATIVE DISORDERS - Ansitu National de la Sant'E de la Cherche Medical

Title:

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PATIENTS SUFFERING FROM MYELOPROLIFERATIVE DISORDERS

Document Type and Number:

Japanese Patent JP2022133455

Kind Code:

A

Abstract:

To provide methods and pharmaceutical compositions for the treatment of myeloproliferative disorders in patients presenting a dysregulation of the JAK2-STAT signaling pathway.SOLUTION: Provided is a method for treating a myeloproliferative disorder in a patient presenting a dysregulation of the JAK2-STAT signaling pathway, comprising administering to the patient a therapeutically effective combination of an interferon polypeptide and an arsenic compound.SELECTED DRAWING: None

Inventors:

Do Tae, Hugues
Cassina, Bruno
Larmmann-Breitenbach, Valery
Professional, isabelle
Villeval, Jean-Luc
Kiradian, Jean-Jack

Application Number:

JP2022110350A

Publication Date:

September 13, 2022

Filing Date:

July 08, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ansitu National de la Sant'E de la Cherche Medical

International Classes:

A61K38/21; A61K31/555; A61K33/36; A61K47/60; A61P35/00; A61P43/00

Attorney, Agent or Firm:

Patent Attorney Corporation Tsukuni

Previous Patent: Anti-TNF Antibodies, Compositions, and Methods for Treating Active Ankylosing Spondylitis

Next Patent: Nanoscale pore-structured cathodes and material synthesis methods for high-power applications